Archer Investment Adds New CVS Position After Reported EPS Beat
Archer Investment Corp reported a new position in CVS Health via its latest SEC 13F filing, buying 24,422 shares worth about $2.53 million. Other investors also increased stakes. CVS reported quarterly EPS of $2.58, exceeding consensus by $0.71, while analysts cited higher price targets and buy/overweight ratings.